The European Medicines Agency (EMA) is recommending Novavax’s Covid-19 vaccine carry a warning of the possibility of two types of heart inflammation, Reuters reported. The heart conditions — myocarditis and pericarditis — should be listed as new side effects for the vaccine, Nuvaxovid, based on a small number of reported cases. Novavaxsaid no concerns about heart inflammations were raised during the clinical trials and that more data would be gathered.
Read and decide
Get instant access to all articles — and 20 years of archives.
Discussion about this post